| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Jeffrey J Brown is Director at UPBD, with reported holdings spanning 3 companies. Jeffrey J Brown's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.3M at current prices.
Our model assigns Jeffrey J Brown a below-average insider score of 48/100, based on 43 past trades. Over a 12-month horizon, 17.9% of those trades were profitable, with an average 12-month return of -26.1%.
Jeffrey J Brown's largest disclosed position is in UPBD as Director, worth about $2.8M. Net of sales, the UPBD filings show accumulation of 123,072 shares.
Jeffrey J Brown has 107 Form 4 filings on record from September 2015 to October 2026, across 3 companies: Director at Upbound Group (UPBD), 2018–2026; Director at Medifast (MED), 2015–2025; Director at Cadiz (CDZI), 2018–2020.
The 175 reported transactions were 81 open-market purchases, 57 option or other derivative awards, 24 stock awards and 6 gifts, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 47 purchases worth about $6.9M and 1 sale worth about $3.5M.
The largest open-market purchase was 26,996 shares of UPBD at an average $55.56 on February 26, 2021, about $1.5M.
The only open-market sale was 38,316 shares of MED at an average $91.14 on August 15, 2023, about $3.5M. Twelve months later MED was down 79%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | UPBD Upbound Group, Inc. | Director | Buy | 2,764 | $17.01 | $47,015.64 | +2.3% | - | - | |
| Jul 7, 2026 | UPBD Upbound Group, Inc. | Director | Buy | 2,295 | $20.09 | $46,106.55 | +2.4% | -23.4% | - | |
| Apr 28, 2026 | UPBD Upbound Group, Inc. | Director | Buy | 2,329 | $19.41 | $45,205.89 | +2.0% | +8.1% | - | |
| Jan 6, 2026 | UPBD Upbound Group, Inc. | Director | Buy | 2,502 | $17.68 | $44,235.36 | +2.8% | -2.6% | - | |
| Oct 21, 2025 | UPBD Upbound Group, Inc. | Director | Buy | 1,951 | $22.27 | $43,448.77 | +2.2% | -16.6% | -29.4% | |
| Jul 8, 2025 | UPBD Upbound Group, Inc. | Director | Buy | 1,653 | $25.90 | $42,812.70 | +1.9% | -15.9% | -22.4% | |
| May 6, 2025 | UPBD Upbound Group, Inc. | Director | Buy | 21,730 | $23.75 | $516,087.50 | New | -9.0% | -18.5% | |
| Apr 22, 2025 | UPBD Upbound Group, Inc. | Director | Buy | 1,694 | $19.89 | $33,693.66 | +2.0% | +15.0% | - | |
| Jan 7, 2025 | UPBD Upbound Group, Inc. | Director | Buy | 1,146 | $29.01 | $33,245.46 | +1.3% | -25.3% | -37.3% | |
| Oct 22, 2024 | UPBD Upbound Group, Inc. | Director | Buy | 1,065 | $29.25 | $31,151.25 | +1.3% | +5.7% | -20.7% |